Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 08:33 am Sale | 13G | ALBIREO PHARMA INC ALBO | Deep Track Capital LP | 0 0% | -1,704,000 (Position Closed) | View |
| 2023-04-10 11:22 am Sale | 13G | ALBIREO PHARMA INC ALBO | FEDERATED HERMES INC. FHI | 0 0% | -1,956,488 (Position Closed) | View |
| 2023-03-08 2:01 pm Sale | 13G | ALBIREO PHARMA INC ALBO | BlackRock Inc. BLK | 506,425 2.4% | -838,472 (-62.34%) | View |
| 2023-03-02 4:26 pm Purchase | 13G | ALBIREO PHARMA INC ALBO | ICS OPPORTUNITIES LTD. | 999,363 4.8% | 999,363 (New Position) | View |
| 2023-02-27 4:05 pm Purchase | 13G | ALBIREO PHARMA INC ALBO | Beryl Capital Management LLC | 1,483,599 7.1% | 1,483,599 (New Position) | View |
| 2023-02-24 5:24 pm Purchase | 13G | ALBIREO PHARMA INC ALBO | CARLSON CAPITAL L P | 1,075,000 5.2% | 1,075,000 (New Position) | View |
| 2023-02-14 4:00 pm Sale | 13G | ALBIREO PHARMA INC ALBO | TANG CAPITAL PARTNERS LP | 411,968 2% | -687,548 (-62.53%) | View |
| 2023-02-14 2:31 pm Sale | 13G | ALBIREO PHARMA INC ALBO | PERCEPTIVE ADVISORS LLC | 1,757,160 8.5% | -602,979 (-25.55%) | View |
| 2023-02-14 08:23 am Purchase | 13G | ALBIREO PHARMA INC ALBO | Deep Track Capital LP | 1,704,000 8.23% | 579,579 (+51.54%) | View |
| 2023-02-01 09:56 am Sale | 13G | ALBIREO PHARMA INC ALBO | STATE STREET CORP STT | 348,114 1.68% | -644,718 (-64.94%) | View |
| 2023-02-01 09:07 am Sale | 13G | ALBIREO PHARMA INC ALBO | FEDERATED HERMES INC. FHI | 1,956,488 9.45% | -402,136 (-17.05%) | View |
| 2023-01-31 5:52 pm Purchase | 13G | ALBIREO PHARMA INC ALBO | BlackRock Inc. BLK | 1,344,897 6.5% | 176,114 (+15.07%) | View |
| 2023-01-23 12:49 pm Purchase | 13G | ALBIREO PHARMA INC ALBO | Chicago Capital LLC | 1,362,484 6.6% | 390,599 (+40.19%) | View |
| 2022-10-03 4:37 pm Purchase | 13G | ALBIREO PHARMA INC ALBO | Deep Track Capital LP | 1,124,421 5.46% | 1,124,421 (New Position) | View |
| 2022-09-26 4:00 pm Purchase | 13G | ALBIREO PHARMA INC ALBO | TANG CAPITAL PARTNERS LP | 1,099,516 5.6% | 1,099,516 (New Position) | View |
| 2022-03-07 08:56 am Purchase | 13G | ALBIREO PHARMA INC ALBO | Chicago Capital LLC | 971,885 5.1% | 971,885 (New Position) | View |
| 2022-02-14 4:10 pm Unchanged | 13G | ALBIREO PHARMA INC ALBO | PERCEPTIVE ADVISORS LLC | 2,360,139 12.2% | 0 (Unchanged) | View |
| 2022-02-14 1:38 pm Sale | 13G | ALBIREO PHARMA INC ALBO | FEDERATED HERMES INC. FHI | 2,358,624 12.23% | -2,922,223 (-55.34%) | View |
| 2022-02-09 4:49 pm Purchase | 13G | ALBIREO PHARMA INC ALBO | STATE STREET CORP STT | 992,832 5.15% | 992,832 (New Position) | View |
| 2022-02-02 7:11 pm Sale | 13G | ALBIREO PHARMA INC ALBO | BlackRock Inc. BLK | 1,168,783 6.1% | -73,997 (-5.95%) | View |